Chen, J.* ; Sathiaseelan, V.* ; Moore, A.D.* ; Tan, S.* ; Chilamakuri, C.S.* ; Roamio Franklin, V.N.* ; Shahsavari, A.* ; Jakwerth, C.A. ; Hake, S.B.* ; Warren, A.J.* ; Mohorianu, I.* ; D'Santos, C.S.* ; Ringshausen, I.*
ZAP-70 constitutively regulates gene expression and protein synthesis in chronic lymphocytic leukemia.
Blood 137, 3629-3640 (2021)
The expression of ZAP-70 in a subset of CLL patients strongly correlates with a more aggressive clinical course, though the exact underlying mechanisms remain elusive. The ability of ZAP-70 to enhance B cell receptor (BCR) signaling, independently of its kinase function, is considered to contribute. Here we employed RNA-sequencing and proteomic analyses of primary cells differing only in their expression of ZAP-70 to further define how ZAP-70 increases aggressiveness of CLL. We identified that ZAP-70 is directly required for cell survival in the absence of an overt BCR signal, which can compensate for ZAP-70 deficiency as an anti-apoptotic signal. In addition, the expression of ZAP-70 regulates the transcription of factors regulating recruitment and activation of T cells, such as CCL3, CCL4 and IL4I1. Quantitative mass spectrometry of double-cross linked ZAP-70 complexes further demonstrated constitutive and direct protein-protein interactions between ZAP-70 and BCR-signaling components. Unexpectedly, ZAP-70 also binds to ribosomal proteins, which is not dependent on, but further increased by BCR-stimulation. Importantly, decreased expression of ZAP-70 significantly reduced MYC-expression and global protein synthesis, providing evidence that ZAP-70 contributes to translational dysregulation in CLL. In conclusion, ZAP-70 constitutively promotes cell survival, microenvironment-interactions and protein synthesis in CLL cells, likely to improve cellular fitness and to further drive disease progression.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
Publication type
Article: Journal article
Document type
Scientific Article
Thesis type
Editors
Keywords
B-cell-receptor; C-myc; Cll; Mutations; Subtype
Keywords plus
Language
english
Publication Year
2021
Prepublished in Year
HGF-reported in Year
2021
ISSN (print) / ISBN
0006-4971
e-ISSN
1528-0020
ISBN
Book Volume Title
Conference Title
Conference Date
Conference Location
Proceedings Title
Quellenangaben
Volume: 137,
Issue: 26,
Pages: 3629-3640
Article Number: ,
Supplement: ,
Series
Publisher
American Society of Hematology
Publishing Place
2021 L St Nw, Suite 900, Washington, Dc 20036 Usa
Day of Oral Examination
0000-00-00
Advisor
Referee
Examiner
Topic
University
University place
Faculty
Publication date
0000-00-00
Application date
0000-00-00
Patent owner
Further owners
Application country
Patent priority
Reviewing status
Peer reviewed
POF-Topic(s)
30202 - Environmental Health
Research field(s)
Allergy
PSP Element(s)
G-505400-001
Grants
European Cooperation in Science and Technology Action "European Network for Innovative Diagnosis and treatment of Chronic Neutropenias"
Cancer Research UK (CRUK)
Specialist Programme from Blood Cancer UK
UK Medical Research Council
Kay Kendall Leukaemia Fund
Wellcome strategic award
Wellcome
Connor Wright Project
Cambridge National Institute for Health Research Biomedical Research Centre
Kay Kendell Foundation
Copyright
Erfassungsdatum
2021-04-29